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Thresholds?
by David P. RaIl*
Many diseases resulting from exposure to foreign
chemicals are delayed in their onset and, to some
extent at least, are irreversible. That is, if the
chemical is removed, the disease continues to prog-
ress, or at least not regress. Typical are the diseases
called cancer. Mutagenic effects, well documented
in laboratory animals but extremely difficult to
document in the human population, also fit into this
category. Chronic liver, lung, and probably kidney
and central nervous system diseases are also long-
delayed and have an element ofirreversibility about
them.
The critical problem involved is whether or not
these chronic irreversible toxic effects are as-
sociated with a threshold. Is there a concentration
of a toxic chemical compound which causes no ill
effects in the population? Ifthere is a threshold and
if the threshold can be determined experimentally,
then cost-benefit analyses are greatly simplified, be-
cause very often the environmental concentration
can be held below the threshold.
Most scientists would agree that a highly potent
carcinogen such as an aflatoxin, nitrosamine, or a
chloromethyl ether is probably perfectly safe at an
exposure level of one molecule, ten molecules, a
hundred molecules, or maybe even a thousand
molecules per mouse or rat or dog or man; but we
all believe that it is totally unsafe to be exposed to
1020, 1021, 1022, or 1023 molecules ofthis same com-
pound (Fig. la). In an isolated situation in a clean
laboratory experiment it is perfectly reasonable to
expect that very low concentrations have such a
low probability ofcausing a deleterious effect as to
be essentially zero. In point of fact, we can never
determine this. To design an experiment to show
whether or not such a statement is correct would
take enormous resources, and, even if the experi-
ment could be performed, the answer would proba-
bly be suspect.
*National Institute of Environmental Health Sciences, Na-
tional Institutes of Health Research Triangle Park, North
Carolina 27709.
The problem really is where along this continuum
from 100 up to 1023 molecules, do you put the little
sign that says, "This is the threshold?" (Fig. lb). I
don't know where that sign should go, and I don't
think anyone knows.
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FIGURE 1. Thresholds for chemicals that cause chronic irreversi-
ble damage.
February 1978 163A more fruitful way to look at this is to ask the
question: "A threshold for whom?" The human
population in the United States, the population we
are trying to protect, is a very large, diverse, geneti-
cally heterogeneous population, exposed to a vari-
ety of toxic agents. Genetic variability to car-
cinogenesis is well documented, and we are begin-
ning to understand some of the causes of this vari-
ability. There is now evidence that the amount of an
enzyme, arene oxidase, oraryl hydroxylase, which is
genetically controlled, may determine the suscepti-
bility to lung cancer from cigarette smoking. If you
have a lot of the enzyme, you tend to be highly
susceptible. If you have a little ofthe enzyme, you
are not particularly susceptible. It is also well
known that people who are deficient in im-
munological competence are particularly suscepti-
ble to cancer. Therefore, any condition-be it
genetic or environmental-that affects immunologic
competence, can also affect susceptibility to
cancer. Individuals who are deficient in DNA re-
pair processes also are more susceptible to cancer.
This is demonstrated by studies of patients with
xeroderma pigmentosa. Such persons are highly
susceptible to ultraviolet induced skin cancer, and it
can be demonstrated that they have deficient DNA
repair.
It seems, therefore, that instead of one sign say-
ing, "This is the threshold," we really need a whole
series oflittle signs, a forest of signs, saying, "This
is the threshold" for this person or this part of the
population (Fig. lc). The question then becomes:
"Whose threshold and when?"
Another way oflooking at the threshold problem
is to consider the curve relating cancer mortality to
the age of the population in the United States; in
this instance it is for 1965 (Fig. 2). There is a smooth
curve ofincreased mortality after the age 35, begin-
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FIGURE 2. Age distribution ofall malignant neoplasms: (O) male
white; (o) male nonwhite; (A) female white; (o) female
nonwhite.
ning to become asymptotic after about age 65 in
blacks, but not whites. This is the same sort of
curve that an oncologist would see, had he ad-
ministered a moderately strong carcinogen to a
large group of experimental animals. In other
words, it looks like a typical dose-response curve
for a carcinogenic substance. This, of course,
strongly suggests that we are all exposed to signifi-
cant amounts of carcinogens. And we know that
there are carcinogenic compounds in our environ-
ment. In most people these carcinogen concentra-
tions are not high enough (or the individuals not
susceptible enough) to cause cancer in their
lifetime.
This I would propose as the added risk factor
rather than the threshold-no threshold debate. I
suggest added risk, but it can be argued that mix-
tures oftwo or more carcinogens are not only addi-
tive but can be synergistic. Indeed, there is some
evidence that there can be actual antagonism be-
tween some carcinogenic substances, but the simple
concept of an additive effect between existing car-
cinogens and a newly introduced one would be most
likely. Since the U. S. population is exposed to
cancer-producing agents, it seems logical that the
addition ofany amount ofa carcinogen will increase
the risk of the cancer appearing, or appearing ear-
lier, and adversely affecting life. It is clear, to me at
least, that adding carcinogens will increase the
probability of death by cancer. It is also clear that
this probability can be very low indeed-that if a
very small amount of carcinogen is added, the in-
creased probability-the added risk factor-will be
in the orderofone inamillion, one in ten million per
year. This, I think, underlines the important efforts
to develop statistical models such as the Bryan-
Mantel model or the linear model to provide an es-
timate of what the increased incidence of cancer
might be with the addition ofvery small amounts of
carcinogens.
But the issue is not thresholds or no thresholds; it
is one of adding a new carcinogen to a pool of pre-
sent carcinogens. I would suggest, therefore, that
there may well be thresholds with carcinogenic sub-
stances when given to a very clean animal in an
environmentally controlled situation, that is, when
there are few or no other carcinogens present; this
is what the experimental oncologist tries to create in
the standard laboratory animal test system-a clean
animal of known and homogeneous genetic
background with a well characterized diet and no
known carcinogens living in sterile filtered air. The
human population is different, however: the mouse
doesn't smoke or breathe hydrocarbons or sulfur
oxides from fossil fuels, doesn't drink, doesn't take
Environmental Health Perspectives 164medicine, doesn't eat bacon or smoked salmon, but
man does.
The current controversy regarding the occur-
rence ofthresholds for carcinogenic and mutagenic
chemicals will in the normal course of scientific
events be resolved as a scientific consensus, but
this will take years to decades. In the meantime,
judgments and regulatory decisions must be made
on the basis of incomplete information.
One wonders however about the implications of
each of the two possible decisions that might turn
out to be wrong.
Ifthresholds do existand the regulatory decisions
are based on a no-threshold concept, there will be
short-term economic losses. If thresholds do not
exist and the regulatory decisions are based on
thresholds, then there will be fewer short-term
economic losses, but we would face a future of
damaged human somatic and germinal DNA and an
increased incidence of neoplastic diseases.
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